Ocular Therapeutix, Inc. Common Stock Earnings Dividend

Ocular Therapeutix, Inc. Common Stock’s revenue jumped 0.12% since last year same period to $13.48Mn in the Q2 2026. On a quarterly growth basis, Ocular Therapeutix, Inc. Common Stock has generated 24.94% jump in its revenue since last 3-months.

Ocular Therapeutix, Inc. Common Stock’s net profit fell -16.15% since last year same period to $-78.76Mn in the Q2 2026. On a quarterly growth basis, Ocular Therapeutix, Inc. Common Stock has generated 11.11% jump in its net profits since last 3-months.

Ocular Therapeutix, Inc. Common Stock’s net profit margin fell -16.01% since last year same period to -584.51% in the Q2 2026. On a quarterly growth basis, Ocular Therapeutix, Inc. Common Stock has generated 28.86% jump in its net profit margins since last 3-months.

Ocular Therapeutix, Inc. Common Stock’s earning per share (EPS) estimates for the current quarter stand at -0.4 - a -29.03% fall from last quarter’s estimates.

Ocular Therapeutix, Inc. Common Stock’s earning per share (EPS) estimates for the current year stand at -0.4.

Ocular Therapeutix, Inc. Common Stock’s earning per share (EPS) jumped 10.26% since last year same period to -0.35 in the Q2 2026. This indicates that the Ocular Therapeutix, Inc. Common Stock has generated 10.26% annual rate of jump in its earning per share (EPS) in the last 4 quarters.